Dr. Sulaiman Al Habib Medical Group (HMG)
Dr. Sulaiman Al Habib Medical Group (HMG) scored 71/100 on Panya's 11-signal vendor rubric. Each signal is scored 0 to 100, the methodology is public, and our affiliate posture is flat-fee — never pay-to-rank. Below is the full per-signal breakdown.
- COA on every lot80
- Cold-chain verifiedJCI-accredited group pharmacy chain85
- Rx legality (SFDA)SCFHS-licensed prescribers95
- Compound identityTadawul-listed (4013), 20+ facilities85
- Dose accuracynamed endo consultants, Obesity Treatment Center80
- Endotoxin testing75
- Refund posture60
- Channel clarity20+ sites, KSA + UAE + Bahrain coverage85
- Support qualityAR/EN, intl-insurance direct-bill80
- Price transparencyobesity program page descriptive; no ladder60
- Longitudinal retentionobesity center multi-disciplinary follow-through70
Cash-pay market, Novo Nordisk and Lilly both maintain steady allocation. DHA / DOH-licensed clinics report no supply gaps in 2026.
MoH-AE registered since 2019. Cash-pay supply steady.
Direct Novo Nordisk allocation deal kept UAE supply steadier than most regions through the 2024-25 shortage.
The 11-signal rubric is public.
Identity, dose accuracy, COA, cold-chain, Rx legality, compound identity, endotoxin testing, refund posture, channel clarity, support quality, price transparency, longitudinal retention. Each scored 0 to 100. Vendors that fail our floor are silently filtered out — they don't appear in our match flow at all.
If Dr. Sulaiman Al Habib Medical Group (HMG) wants to dispute or update this score, contact partner@panya.health. Score updates are recorded on this page with a public changelog.
Want a match for your situation?
Take the 2-minute quiz. We'll match you against this and the other vendors in your region — based on your dose, urgency, and budget.
We earn a small commission when you buy through recommended vendors. That is how this stays free. Vendors rank by quality signals, not paid placement.